(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EMERGING THERAPY SOLUTIONS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EMERGING THERAPY SOLUTIONS

ST13

US500000088051774

Class

35, 36, 44

Filing

88051774

Registration

5864468

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

06/25/2026

Trademark type

Word

Nice classes

35, 36, 44

Filing date

07/25/2018

Registration date

09/17/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/25/2026

Last transaction

06/25/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

08/31/2017

First use in commerce

08/31/2017

Drawing code

4

Owner type

03

Owner location

Bloomington, MN, US

Examiner

SANTOMARTINO, MARTHA L

Current location

Historical data usage

Holders and representatives

Holders

Emerging Therapy Solutions, Inc.
Emerging Therapy Solutions, Inc.

Representatives

Cynthia A. Moyer Fredrikson & Byron, P.A.

Technical classification

Nice Classes

Class 35Class 36Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business management and consulting services for the health care industrybusiness management of cellgene and other complex medical therapies for health planshealth insurersself-funded plansreinsurers; business management and administration in the field of healthcaredevelopmentcreation and implementation of health care provider networks; business administration of cellgene and other complex therapy programs

Class 36

Financial consultation to healthcare providersproviding assistance in obtaining reimbursement of health care expenses related to cellgene and other complex therapies

Class 44

Consulting services in the field of medical caredeveloping medical treatment policies related to cellgeneother complex therapies; medical information services related to cellgene and other complex therapies

Publications

History of USPTO decisions and trademark events.

29 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

06/25/2026

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

06/25/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/25/2026

ES8R

TEAS SECTION 8 RECEIVED

03/17/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/17/2024

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

09/17/2019

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/12/2019

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

08/05/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/11/2019

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

07/11/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/10/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/10/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/10/2019

GNRT

NON-FINAL ACTION E-MAILED

07/10/2019

IUAA

USE AMENDMENT ACCEPTED

07/10/2019

CNRT

NON-FINAL ACTION WRITTEN

07/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/28/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/28/2019

ALIE

ASSIGNED TO LIE

05/28/2019

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

05/24/2019

IUAF

USE AMENDMENT FILED

05/24/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/23/2019

EAAU

TEAS AMENDMENT OF USE RECEIVED

05/23/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/26/2018

GNRT

NON-FINAL ACTION E-MAILED

11/26/2018

CNRT

NON-FINAL ACTION WRITTEN

11/26/2018

DOCK

ASSIGNED TO EXAMINER

11/13/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/30/2018

NWAP

NEW APPLICATION ENTERED

07/28/2018

Continuous trademark protection

Get notified about every new filing that threatens EMERGING THERAPY SOLUTIONS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.